Amorepacific Holdings Corp. · KRX:002790

Amorepacific — Q2 2015 Earnings Presentation

8 slides from Amorepacific's earnings presentation, 2015

1. Slide 1: AMOREPACIFIC GROUP 2Q 2015 Earnings Release

   AMOREPACIFIC GROUP 2Q 2015 Earnings Release 1 1H 2015 Earnings Summary 2 2Q 2015 Earnings Summary 3 Earnings by Subsidiary 4 Financial Summary As a note, it is suggested to use this material only as a reference, as it contains information and data that are subject to changes without prior notice due

2. Slide 2: 1H 2015 Earnings Summary

   ㅣ 1H 2015 Earnings Summary 2Q 1 2015 Sales up 23.3% to KRW 2,857.0bn, OP up 46.1% to KRW 564.3bn Sales & OP by Division KRW bn 1H 2014 % of sales 1H 2015 % of sales YoY(%) Sales 23,16.5 100.0 2,857.0 100.0 23.3 Operating 2,235.9 96.5 2,772.1 97.0 24.0 subsidiaries1) Manufacturing 80.6 3.5 84.9 3.0 5

3. Slide 3: 2Q 2015 Earnings Summary

   ㅣ 2Q 2015 Earnings Summary 2Q 1 2015 Sales & OP by Division KRW bn 2Q 2014 % of sales 2Q 2015 % of sales YoY(%) Sales 1,176.8 100.0 1,413.2 100.0 20.1 Operating 1,135.0 96.4 1,372.1 97.1 20.9 subsidiaries1) Manufacturing 41.8 3.6 41.0 2.9 -1.9 subsidiaries & others2) 2Q 2014 OPM 2Q 2015 OPM YoY(%) O

4. Slide 4: Earnings by Subsidiary (1/3)

   ㅣ Earnings by Subsidiary(1/3) 2Q 2 2015 Operating subsidiaries Manufacturing subsidiaries & others Sales Sales 20.9% 1,372.1 17.4% 15.6 2.3% 1,135.0 28.8 64.4 6.8 9.2% -1.9% -7.1% Amos Professional 13.2 146.5 41.8 41.0 28.1 26.5% Aestura 6.2 69.3 Espoir Etude 115.8 Innisfree 1,195.4 23.7% AMOREPACIF

5. Slide 5: Earnings by Subsidiary (2/3)

   ㅣ Earnings by Subsidiary(2/3) 2Q 3 2015 AMOREPACIFIC Sales +24%, OP 38% Domestic Cosmetics AMOREPACIFIC_Consolidated 2Q 2014 2Q 2015 Sales 966.7 1,195.4 GP 715.9 909.0 SG&A expenses 564.8 700.9 OP 151.1 208.0 Mass & Sulloc Innisfree Sales 115.8 146.5 Overseas Business GP 81.3 101.3 SG&A expenses 61.

6. Slide 6: Earnings by Subsidiary (3/3)

   ㅣ Earnings by Subsidiary(3/3) 2Q 4 2015 Espoir Sales +9%, Mitigated losses Espoir 2Q 2014 2Q 2015 Sales 6.2 6.8 GP 4.6 5.4 Aestura (Pacific Pharma.) Sales +2%, OP +19% SG&A expenses 5.9 6.3 OP -1.3 -0.9 Aestura (Pacific Pharma.) Sales 28.1 28.8 Amos Professional Sales +17%, OP 27% GP 6.2 6.4 SG&A ex

7. Slide 7: Financial Summary

   ㅣ Financial Summary 2Q 5 2015 Income Statement KRW bn Statements of Financial Position KRW bn 2Q 2014 2Q 2015 2014.12 2015.06 Sales 1,176.8 100.0% 1,413.2 100.0% Assets 5,499.7 5,881.0 Gross Profit 853.4 72.5% 1,067.7 75.5% Current assets 2,098.1 2,386.5 SG&A expenses 681.1 57.9% 823.8 58.3% Non-cur

8. Slide 8: AMORE PACIFIC Years of Beauty Creation

   AMORE PACIFIC 70 Years of Beauty Creation

AMOREPACIFIC Group — Q2 2015 Earnings Presentation on 6ix